RAG-01

N/A

Report date: 2026/03/16 16:40:12
NMEFirst In Class

Base Information

Drug NameRAG-01
Drug Alias NameRAG-01
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > small activating RNA
Mechanisms of ActionRNA stimulantsGene expression stimulants
TargetsRibonucleic Acid
Therapy Area/IndicationsUrinary Bladder NeoplasmsVaginal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesRactigen Therapeutics (Nantong) Co LtdRactigen Therapeutics (Nantong) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesRactigen Therapeutics (Nantong) Co Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsVaginal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A